Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piroxicam mesotherapy vs subcutaneous normal saline for knee osteoarthritis pain
IRCT20260421069125N1Phase 3Recruiting
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of piroxicam in knee osteoarthritis (OA) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Pain intensity in knee osteoarthritis. Started May 2026; status: recruiting.
02
Drugs
piroxicam
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20260421069125N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260421069125N1.